I-Chen Wu | Gastroenterology | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. I-Chen Wu | Gastroenterology | Best Researcher Award

Prof. Dr. I-Chen Wu, Kaohsiung Medical University, Taiwan

Prof. Dr. I-Chen Wu is a distinguished physician-scientist and academic leader at Kaohsiung Medical University (KMU), Taiwan. With over two decades of experience in gastroenterology and internal medicine, she currently serves as Associate Dean of KMU’s College of Medicine and Director of the Digestive Disease Center at KMUH. Her leadership roles span national medical societies and regulatory bodies, reflecting her impact on healthcare policy, clinical innovation, and education. Dr. Wu is widely recognized for her contributions to esophageal cancer management and smart endoscopy technology, earning numerous accolades for her research excellence and academic service. 🏅📚

Publication Profile

Scopus

Orcid

🎓 Education

Dr. Wu earned her MD from National Taiwan University (1994–2001), laying the foundation for her clinical expertise. She pursued her PhD at the Graduate Institute of Medicine, KMU (2005–2008), specializing in medical sciences. Her academic journey expanded globally with a postdoctoral fellowship as a Visiting Scientist in Occupational Health at the Harvard School of Public Health (2009–2010). This robust educational background integrates local excellence and international experience, equipping her with interdisciplinary knowledge and a global perspective that underpin her clinical, academic, and research achievements. 🏥📖🌏

💼 Experience

Dr. Wu has held key academic and hospital positions, including Professor of Medicine at KMU and Chief of Gastroenterology at KMUH. Her clinical journey began in 2006 as an attending physician, and she progressed to leading digestive endoscopy and cancer management teams. She’s also served on KMUH’s Institutional Review Board and national advisory councils, including Taiwan’s FDA. Beyond hospital and academic roles, she has actively shaped professional societies related to endoscopy, neuroendocrine tumors, and gastric cancer. Her career demonstrates sustained commitment to clinical excellence, research leadership, and institutional development. 👩‍⚕️🏨📈

🏆 Awards and Honors

Dr. Wu’s outstanding contributions have been recognized with numerous honors. These include the ASCO Merit Award (2015), National Innovation Award (2020), and Young Investigator Award (2014). She’s a recipient of multiple Excellent Poster Awards, KMU’s Outstanding Research Awards (2011–2022), and the Symbol of National Quality (SNQ) for her innovative cancer care model. In addition, she earned the Outstanding Teaching Award and the Collaborative Research Outstanding Scholar Award. These accolades reflect her dedication to pioneering research, impactful teaching, and the advancement of medical science. 🥇📜🏅

🔬 Research Focus

Dr. Wu’s research centers on gastroenterology, with a particular emphasis on esophageal cancer, digestive endoscopy innovations, and multidisciplinary cancer care models. She integrates clinical practice with translational research, focusing on early detection, safety, and smart technologies like endoscope medical displays. Her public health work also spans occupational health, stemming from her time at Harvard. Her studies have influenced national guidelines and health technology standards in Taiwan. Through her cross-disciplinary projects, she continues to drive innovations in cancer management, patient care models, and drug safety. ⚕️🧫📊

Publication Top Notes

  • 🧪 Phyto-Sesquiterpene Lactones Prevent the Development of Multidrug Resistance in TNBC via ABC Transporters Inhibition and STAT3/MYC Signaling, Cancers, 2025

  • 💊 Cost-effectiveness of universal esophageal cancer screening for newly diagnosed oral cancer patients, Journal of Gastroenterology and Hepatology, 2024

  • 🔬 Computer-aided endoscopic diagnostic system modified with hyperspectral imaging for the classification of esophageal neoplasms, Frontiers in Oncology, 2024

  • 🧫 The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan, Journal of Microbiology, Immunology and Infection, 2024

  • 🧠 Advancements in Hyperspectral Imaging and Computer-Aided Diagnostic Methods for the Enhanced Detection and Diagnosis of Head and Neck Cancer, [Journal Name Not Specified], 2024 – 2 citations.​

  • 🧪 A phase 1 study of biweekly nab-paclitaxel/ oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOGT1216 study, Oncologist, 2024

 

Slobodan Simonovic | Water resources management | Best Researcher Award

Posted on by ScienceFather

Prof. Slobodan Simonovic | Water resources management | Best Researcher Award

Prof. Slobodan Simonovic, Western University, Canada

Prof. Slobodan P. Simonovic is a globally renowned expert in water resources engineering and systems analysis. A Fellow of the Royal Society of Canada, Canadian Academy of Engineering, and Serbian Academy of Sciences and Arts, he has significantly contributed to climate resilience, hydrology, and disaster risk management. Through academic leadership, groundbreaking research, and impactful consulting, he bridges science, society, and sustainability. He has published over 650 works, mentored future leaders, and led international collaborations. His consulting firm has delivered over 90 engineering and capacity-building projects. Prof. Simonovic is celebrated globally for advancing sustainable and resilient water infrastructure solutions. 🌍📚💧

Publication Profile

Google Scholar

🎓 Education

Prof. Simonovic completed his BSc and MSc in Civil Engineering at the University of Belgrade, specializing in hydrotechnics. He later earned his PhD in Systems Engineering from the University of Manitoba, Canada. His education integrated engineering principles with complex systems analysis, setting the foundation for a pioneering career in interdisciplinary water resources research. His academic background is distinguished by a deep understanding of both theoretical frameworks and applied engineering practices, particularly in the sustainable management of natural and engineered water systems. This rigorous education has empowered him to drive impactful innovation in climate change resilience and infrastructure systems. 🎓📘🔬

💼 Experience

Prof. Simonovic has over four decades of academic, research, and consulting experience in civil and environmental engineering. He served at the University of Manitoba and later joined Western University, where he established the Institute for Catastrophic Loss Reduction. He has held visiting positions worldwide and served in advisory roles for international organizations including UNESCO and IAHS. Through his consultancy, he completed over 90 engineering and capacity-building projects globally. His leadership in academia and industry has influenced policies, built global partnerships, and delivered real-world solutions in water resources, flood management, and climate adaptation. 🌐🏗️📊

🏆 Awards and Honors

Prof. Simonovic has received over 60 prestigious awards, including Fellowships from the Royal Society of Canada, Canadian Academy of Engineering, and American Society of Civil Engineers. He received the Ven Te Chow Award (ASCE), Environmental Sciences in Canada Leader Award (Research.com), and EWRA Award for outstanding contributions in water management. Recognitions from China, Brazil, Japan, and Serbia highlight his international impact. He’s also a Distinguished Fellow of the Core Academy and Sigma Xi. His accolades span academic excellence, professional engineering practice, global outreach, and national service—testament to a lifetime dedicated to scientific and societal advancement. 🏅🌎🧠

🔬 Research Focus

Prof. Simonovic’s research focuses on systems analysis, integrating deterministic and stochastic modeling, optimization, and decision-making for complex infrastructure and environmental systems. He applies these tools to water resources management, flood resilience, climate change adaptation, and disaster risk reduction. A pioneer in modeling risk and resilience, his interdisciplinary approach bridges engineering, society, and sustainability. His work informs public policy and advances tools for climate-resilient infrastructure. His cutting-edge simulations and frameworks enable effective planning under uncertainty, helping governments and industries worldwide manage environmental risks in a changing world. 🔍🌧️📈

Publication Top Notes

  • Short term streamflow forecasting using artificial neural networks 📊🌊 – Cited by 776 – 1999

  • Reservoir systems analysis: closing gap between theory and practice 💧📚 – Cited by 470 – 1992

  • Managing water resources: methods and tools for a systems approach 🌍🔧 – Cited by 423 – 2012

  • World water dynamics: global modeling of water resources 🌍💧 – Cited by 414 – 2002

  • System dynamics modeling of reservoir operations for flood management 🚰🌊 – Cited by 379 – 2000

  • Global water resources modeling with an integrated model of the social–economic–environmental system 🌐🌊 – Cited by 350 – 2011

  • Optimization of water distribution network design using differential evolution 🔧💡 – Cited by 298 – 2010

  • A fuzzy compromise approach to water resource systems planning under uncertainty 🌫️💧 – Cited by 293 – 2000

  • Increase of flood risk due to urbanisation: a Canadian example 🏙️🌧️ – Cited by 276 – 2007

  • Computer-based model for flood evacuation emergency planning 🚨🌊 – Cited by 275 – 2005

Alexander Bukreyev | Virology | Excellence in Research

Posted on by ScienceFather

Prof. Dr. Alexander Bukreyev | Virology | Excellence in Research

Prof. Dr. Alexander Bukreyev, University of Texas Medical Branch at Galveston, Excellence in Research

Prof. Dr. Alexander Bukreyev is a Distinguished Professor of Virology and Vaccinology at the University of Texas Medical Branch (UTMB). He serves in the Departments of Pathology and Microbiology & Immunology and holds senior roles in multiple UTMB research centers, including the Sealy Institute for Vaccine Sciences and the Center for Biodefense. An expert in emerging infectious diseases, he is a Fellow of the American Academy of Microbiology. With decades of experience in RNA virus research and BSL-4 pathogen handling, he contributes globally through advisory roles, WHO collaborations, and international vaccine initiatives. 🇺🇸

Publication Profile

Google Scholar

🎓 Education

Prof. Bukreyev earned his Ph.D. in Molecular Biology in 1993 from the State Research Center of Virology and Biotechnology “Vector” in Russia, where he completed the full nucleotide sequencing of the Marburg virus genome. He obtained his M.S. in Pharmacy from Pyatigorsk Pharmaceutical Institute in 1984. His postgraduate education includes extensive biosafety, immunology, and virology training at institutions such as NIH and UTMB. His education reflects a lifelong commitment to combating viral diseases and advancing vaccine science through foundational knowledge and specialized high-containment lab training. 🧬📘

💼 Experience

Prof. Bukreyev currently serves as a professor at UTMB and has been affiliated with the university since 2010. Prior to this, he was a Staff Scientist and Research Fellow at the NIH’s National Institute of Allergy and Infectious Diseases from 1995 to 2010, working under Dr. Robert Chanock and Dr. Peter Collins. His early career in Russia included senior research roles at the Vector Institute, where he specialized in RNA viruses and high-level biosafety. Across his career, he has led multiple research teams, mentored fellows, and managed work in BSL-3 and BSL-4 labs. 🧪🔬

🏆 Awards and Honors

Prof. Bukreyev was elected Fellow of the American Academy of Microbiology in 2025 and received the UT System STAR Award in 2024. He has convened and co-chaired major international workshops on RNA vaccines and host defense, including for the International Society for Vaccines and the American Society for Virology. He has served on the WHO COVID-19 Animal Model Expert Group and numerous scientific planning committees. His honors reflect global recognition of his leadership in vaccine development, viral immunology, and infectious disease research. 🌍🥇

🔬 Research Focus

Prof. Bukreyev’s research centers on the molecular biology, immunopathology, and vaccinology of emerging RNA viruses, including filoviruses (e.g., Ebola and Marburg), respiratory syncytial virus, and SARS-CoV-2. He develops and evaluates novel vaccine candidates, focusing on live-attenuated and vector-based platforms, and studies viral mechanisms that interfere with host immunity. His lab also explores immune correlates of protection and animal model development. With extensive expertise in BSL-4 pathogens, his work supports global biodefense and pandemic preparedness. 🦠💉

Publication Top Notes

  • 📚 Taxonomy of the order Mononegavirales: update 2016 – 568 citations, 2016

  • 🦠 Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice – 532 citations, 2004

  • 🧬 2020 taxonomic update for phylum Negarnaviricota… – 398 citations, 2020

  • 📖 Taxonomy of the order Mononegavirales: update 2019 – 380 citations, 2019

  • 🧫 Infection of ciliated cells by human parainfluenza virus type 3… – 372 citations, 2005

  • 🧪 Recombinant respiratory syncytial virus with deleted SH gene… – 337 citations, 1997

  • 🧍‍🦍 Recombinant RSV with deletion of NS2 or SH gene attenuated in chimpanzees – 333 citations, 1999

  • 💉 Mucosal immunisation in African green monkeys using attenuated parainfluenza virus… – 332 citations, 2004

  • 🛡 Structural proteins of SARS-CoV contribute to protective immunity – 314 citations, 2004

  • 🔬 Taxonomy of the order Mononegavirales: update 2017 – 275 citations, 2017

Leila Omidi | Human Factors | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Leila Omidi | Human Factors | Best Researcher Award

Assist. Prof. Dr. Leila Omidi, Tehran University of Medical Sciences, Iran

Assist. Prof. Dr. Leila Omidi is a faculty member at the Department of Occupational Health Engineering, Tehran University of Medical Sciences, Iran. She specializes in safety engineering, resilience, and risk analysis. Dr. Omidi has led several national projects focused on hospital and industrial safety systems and serves as an international representative of her department. She is also actively involved in academic publishing, serving as Managing Editor and Scientific Editor for occupational health journals. Her work integrates theory and real-world applications, especially in high-risk environments, reflecting her deep commitment to advancing health and safety performance in both academic and industrial contexts. 👩‍🏫

Publication Profile

Scopus

🎓 Education

Dr. Leila Omidi holds a Ph.D. and M.Sc. in Occupational Health and Safety Engineering from Tehran University of Medical Sciences and Shahid Beheshti University of Medical Sciences, respectively. Her doctoral research focused on optimizing risk-based resilience in fire systems within oil refineries, while her master’s work explored simulation-based strategies for reliability-centered maintenance. Her academic background is deeply rooted in the integration of safety engineering, risk analysis, and system resilience. She has received fellowships and national recognition for academic excellence and has been acknowledged as an exceptional talent by Iran’s National Elites Foundation. Her education uniquely blends safety science with engineering innovation. 🎓📚

🛠 Experience

Dr. Omidi has been serving as Assistant Professor at Tehran University of Medical Sciences since 2021. She has extensive teaching experience in occupational health, process safety, accident analysis, and human error at both graduate and undergraduate levels. Beyond academia, she has held roles as a health expert for Iran’s Ministry of Health and served as a safety advisor in industrial settings, including Gam Metal Casting and MizanBinazir Industrial Company. She has also contributed to academic publishing as Managing Editor of the Journal of Health and Safety at Work and as a Scientific Editor for Journal of Iran Occupational Health. 🏥🧪

🏅 Awards and Honors

Dr. Omidi has received numerous awards and fellowships recognizing her academic excellence and research contributions. She was twice awarded as the top student of her department during her MSc studies and acknowledged as an exceptional talent by the National Elites Foundation of Iran. She earned a Doctoral Dissertation Fellowship and multiple research grants from leading universities and ministries. Notably, her work in traffic safety, resilience engineering, and human error has been funded by institutions such as Tehran, Tabriz, and Iran University of Medical Sciences. Her contributions have elevated safety performance research in both healthcare and industrial sectors. 🎖️🏆

🔬 Research Focus

Dr. Omidi’s research focuses on process safety, human reliability analysis (HRA), risk assessment, and resilience engineering, with a special interest in safety performance metrics and safety culture. She investigates complex systems such as fire suppression networks in oil refineries and human factors in hospital evacuation. Her interdisciplinary studies integrate simulation tools, decision-making models, and reliability-centered strategies to enhance system safety. Her goal is to bridge theoretical frameworks and applied practices in high-risk environments like healthcare, chemical industries, and public health systems. Her recent projects explore novel approaches to vulnerability, safety citizenship behavior, and mindful organizing in safety-critical domains. 🔍🧯

Publication Top Notes

📘 “Resilience assessment in process industries: A review of literature” – M. Ghaljahi, L. Omidi, A. Karimi | Year: N/A | Cited by: 0 📉

📘 “Safety leadership and safety citizenship behavior: the mediating roles of safety knowledge, safety motivation, and psychological contract of safety” – L. Omidi, H. Karimi, C.J. Pilbeam, S. Mousavi, G.R. Moradi | Year: 2025 | Cited by: 3 📈

📘 “Evaluation of Domino Effects and Vulnerability Analysis of Oil Product Storage Tanks Using Graph Theory and Bayesian Networks in a Process Industry” – M. Ghaljahi, L. Omidi, A. Karimi | Year: 2024 | Cited by: 1 🔍

Maria Carmen Asensio | Energy | Women Researcher Award

Posted on by ScienceFather

Prof. Maria Carmen Asensio | Energy | Women Researcher Award

Prof. Maria Carmen Asensio, Materials Science Institute of Madrid – CSIC, Spain

Prof. Maria Carmen Asensio is a leading solid-state physicist and Permanent Research Staff at the Institute of Material Science of Madrid (ICMM-CSIC), Spain. She is the co-founder of the Research Associated Unit MATINÉE and a global expert in synchrotron radiation techniques. Her innovations include the development of the nanoARPES technique for chemical and electronic imaging. With over 265 publications and more than 11,500 citations, she is recognized internationally for her contributions to condensed matter physics. Her collaborative work spans multiple prestigious institutions across Europe, and she plays key roles in scientific leadership, editorial boards, and European research evaluation panels. 🌍📚

Publication Profile

Orcid

Google Scholar

🎓 Education

Prof. Asensio began her academic journey in Argentina, where she earned her foundational degrees in physics. She further advanced her academic career in Europe, undertaking postdoctoral research at the University of Warwick (UK) and the Fritz Haber Institute of the Max Planck Society (Germany). Her interdisciplinary training across premier European laboratories solidified her expertise in spectroscopic methods and materials science. This diverse academic foundation equipped her with the skills to pioneer advanced techniques in synchrotron-based photoemission and solid-state physics, culminating in significant contributions to the electronic structure of novel materials. 🎓🇦🇷🇬🇧🇩🇪

💼 Experience

Prof. Asensio has held prestigious roles including Senior Lecturer at the Autonomous University of Madrid, and postdoctoral fellow at Warwick and the Fritz Haber Institute. Since 1992, she has been a senior member of the GREENER group at ICMM-CSIC, Spain. She has directed major European research projects, chaired the IUVSTA Surface Science Division since 2016, and served as Scientific Director of IUVSTA from 2004 to 2007. As an evaluator for the European Research Council (ERC) and editorial board member of several journals, she has contributed significantly to research governance and scientific development across Europe. 🧪🌐

🏆 Awards and Honors

Prof. Asensio has received six SEXENIOS (Exceptional Productivity Supplements) from the Spanish Government in recognition of sustained research excellence. She was elected Scientific Director of IUVSTA and currently chairs its Surface Science Division. She has supervised numerous award-winning PhD theses and postdoctoral researchers supported by prestigious programs like Marie Curie and CNRS. Her impactful publication on silicene alone has over 3600 citations. Her continuous recognition by institutions like the ERC and international journals underscores her global scientific influence and the pioneering quality of her work in photoemission and advanced materials. 🥇🔖

🧪 Research Focus

Prof. Asensio’s research centers on the electronic and structural characterization of advanced materials using synchrotron radiation techniques such as ARPES, SR-PES, and XAS. Her groundbreaking work in developing nanoARPES allows for nanoscale chemical and electronic imaging. She investigates Fermi surface topology, low-dimensional materials, and electronic instabilities at surfaces and interfaces. Her studies have advanced understanding of graphene, silicene, and other 2D systems, making her a global leader in condensed matter physics and spectroscopic innovation. Her work bridges fundamental physics with instrumentation development for next-generation materials. 🔬📡📊

Publication Top Notes

📖 Silicene: compelling experimental evidence for graphenelike two-dimensional silicon 🔢 4280 📅 2012
📖 Band Alignment and Minigaps in Monolayer MoS₂-Graphene van der Waals Heterostructures 🔢 366 📅 2016
📖 Towards high quality CVD graphene growth and transfer 🔢 339 📅 2015
📖 Quasicrystalline 30° twisted bilayer graphene as an incommensurate superlattice 🔢 245 📅 2018
📖 Evidence of Dirac fermions in multilayer silicene 🔢 233 📅 2013
📖 Black arsenic: a layered semiconductor with extreme in‐plane anisotropy 🔢 232 📅 2018
📖 Topology of the Pseudogap and Shadow Bands in cuprates at optimum doping 🔢 231 📅 1997
📖 Dynamical fluctuations as the origin of a surface phase transition in Sn/Ge(111) 🔢 221 📅 1999
📖 Direct Observation of Interlayer Hybridization in Graphene/MoS₂ heterostructures 🔢 204 📅 2015
📖 Charge Density Wave State Suppresses Ferromagnetic Ordering in VSe₂ Monolayers 🔢 189 📅 2019
📖 Self-aligned silicon quantum wires on Ag(110) 🔢 180 📅 2005
📖 Polycrystalline graphene with single crystalline electronic structure 🔢 176 📅 2014
📖 Observation of a 2D liquid of Fröhlich polarons at SrTiO₃ surface 🔢 172 📅 2015
📖 Chitosan-coated MIL-100(Fe) nanoparticles as bio-compatible nanocarriers 🔢 162 📅 2017

Anine Crous | Genetics | Best Researcher Award

Posted on by ScienceFather

Dr. Anine Crous | Genetics | Best Researcher Award

Dr. Anine Crous at University of Johannesburg, South Africa

Dr. Anine Crous is a Senior Lecturer and Researcher at the University of Johannesburg’s Laser Research Centre, specializing in laser therapy and stem cell research. With a PhD in Biomedical Technology, Dr. Crous is dedicated to advancing knowledge in photobiomodulation and regenerative medicine. She has a strong academic presence, publishing peer-reviewed articles and securing multiple research grants. Committed to mentorship and community engagement, she actively supervises postgraduate students and maintains leadership roles in scientific organizations. 🧑‍🔬📚🌱

Publication Profile

Google Scholar

Academic Background

Dr. Crous earned her PhD in Biomedical Technology from the University of Johannesburg, focusing on lung cancer and stem cell responses to photodynamic therapy. She also holds a cum laude M-Tech in Biomedical Technology, exploring the effects of low-intensity laser irradiation on lung cancer stem cells. Additionally, she obtained a B-Tech in Biomedical Technology and an N.Dip in the same field, all from the University of Johannesburg. 🎓📖🧬

Professional Background

Dr. Crous has a diverse academic career, currently lecturing in Immunology and Research Methods at the University of Johannesburg. She has been involved in research design, grant writing, and publishing findings. Dr. Crous has supervised postgraduate students, including PhD and postdoctoral researchers, and has gained experience in laboratory management and mentorship throughout her academic roles. She has contributed significantly to international conferences and collaborations in the fields of laser therapy and stem cell research. 🧑‍🏫🔬💼

Awards and Honors

Dr. Crous has received multiple accolades for her academic and research excellence. She holds an NRF Y-rating and has secured prestigious funding, such as the NRF Thuthuka Initiative and the SAMRC EIP grant. Her research contributions have earned her recognition within scientific communities, with numerous invitations to present at international conferences. Additionally, she has received various bursaries and fellowships throughout her academic career. 🏆🎖️💡

Research Focus

Dr. Crous’ research focuses on the therapeutic applications of laser therapy and stem cells, particularly in the fields of photobiomodulation and regenerative medicine. Her work aims to advance cancer treatment through nanoparticle-mediated drug delivery and to explore innovative approaches in stem cell differentiation. She is also dedicated to understanding the cellular responses to phototherapy and how it can be used to regenerate damaged tissues. 💡🧬🌿

Publication Top Notes

Conclusion

Dr. Anine Crous is an exemplary candidate for the Research for Best Researcher Award due to her extensive expertise in laser therapy and stem cell research, demonstrated through her significant academic contributions, including numerous peer-reviewed publications and high h-index scores on Google Scholar and Scopus. Her strong mentorship and supervision of postgraduate and postdoctoral students further highlight her commitment to advancing the next generation of researchers. With active involvement in community service, leadership roles, and continuous professional development, Dr. Crous has shown an unwavering dedication to both scientific excellence and societal impact, making her a distinguished researcher on both national and international stages.

 

 

Arooj Naseer | Diversity | Best Researcher Award

Posted on by ScienceFather

Dr. Arooj Naseer | Diversity | Best Researcher Award

Assistant Professor at University of the Punjab, Lahore, Pakistan

Dr. Arooj Naseer is a seasoned academic and researcher serving as Assistant Professor (BPS-19) at the Institute of Botany, University of the Punjab, Lahore. With 18 years of university-level teaching and a distinguished research record, she has significantly contributed to fungal taxonomy and plant sciences. As an HEC-approved PhD supervisor, she mentors future scientists while actively leading national and international research initiatives. Her dedication to education, discovery of new fungal species, and consistent scholarly output make her a key figure in Pakistan’s botanical research landscape. 🌱📚🧬

Publication Profile

Google Scholar

Academic Background

Dr. Naseer holds a PhD in Botany from the University of the Punjab, Lahore, where she also earned her MSc with distinction, receiving two gold medals. Her academic journey began with a BSc (also with distinction and Roll of Honour) at the same university. She completed her F.Sc from Queen Mary College, Lahore, and achieved first position in Matriculation from B.S.I.E Gujranwala. Her education reflects excellence at every level, highlighting a lifelong commitment to academic and scientific distinction. 🎓🏅📖

Professional Background

With 18 years of teaching experience at the University of the Punjab, Dr. Naseer has mentored numerous undergraduate, postgraduate, and doctoral students. Her supervisory portfolio includes guiding 5 PhD candidates, 22 MS/MPhil theses, and 18 BS/MSc research projects. Beyond teaching, she has led and collaborated on multiple research initiatives, including four international projects and eight nationally funded grants. Her rich experience spans instruction, research supervision, and academic administration, making her a respected educator and scientific mentor. 🧑‍🏫📊👩‍🔬

Awards and Honors

Dr. Naseer has been recognized multiple times for her academic excellence and research contributions. She is an HEC-approved PhD supervisor, a prestigious national distinction. Her academic record includes two gold medals, a Roll of Honour, and first position in matriculation. She has received two international travel awards, showcasing her global academic presence. These accolades affirm her status as a dedicated scholar and researcher of high repute, contributing to  both nationally and internationally to the scientific community. 🏆🎖️🌍

Research Focus

Dr. Arooj Naseer’s primary research focus lies in mycology and fungal taxonomy, with 44 fungal taxa described as new to science—a remarkable achievement in biodiversity and systematics. Her broader interests include plant pathology and conservation, supported by her leadership in international projects and successful grant applications. With 55 research papers and a total impact factor of 121.49, she continues to explore the fungal diversity while mentoring emerging scientists. Her work supports sustainable ecosystems and enhances understanding of plant-fungal interactions. 🔬🌿🧫

Publication Top Notes

Fungal Planet description sheets: 1182–1283
Year: 2021 | Cited by: 145 | 📚

A simple spot test quantification method to determine formaldehyde in aqueous samples
Year: 2016 | Cited by: 51 | 🧪

Fungal Planet description sheets: 1436–1477
Year: 2022 | Cited by: 41 | 📑

The 2024 Outline of Fungi and fungus-like taxa
Year: 2024 | Cited by: 37 | 🧬

Conclusion 

Dr. Arooj Naseer is a highly accomplished academic and researcher with 18 years of teaching experience at the University of the Punjab, Lahore. She has made significant contributions to botany and fungal taxonomy, with 55 publications and an impressive total impact factor of 121.49. Her research expertise is underscored by the discovery of 44 new fungal taxa, alongside leading 4 international projects and securing 8 national research grants. As an HEC-approved PhD supervisor, she has mentored numerous students at various academic levels. Dr. Naseer’s international recognition is further reflected in her 2 travel awards. Her combination of research excellence, mentorship, and recognition makes her a highly deserving candidate for the Best Researcher Award.

 

 

Anca Lucau-Danila | Nutrigenomics | Best Researcher Award

Posted on by ScienceFather

Dr. Anca Lucau-Danila | Nutrigenomics | Best Researcher Award

Dr. Anca Lucau-Danila, University of Lille, France

Dr. Anca Lucau-Danila is an Associate Professor at the University of Lille, France, specializing in bioecology and agronomy. With a career spanning over two decades, she is a researcher at UMRt1158 BioEcoAgro and a leader of the “Chicory for One Health” joint team. She has published extensively, guided numerous PhD students and postdoctoral researchers, and contributed significantly to functional genomics, microbiome studies, and plant physiology. Her multidisciplinary expertise has shaped advancements in both academia and research. 🌿🔬🌍

Publication Profile

Orcid

Education

Dr. Lucau-Danila holds a PhD in Agronomy from the University Transilvania, Romania (1996). She completed postdoctoral studies in molecular biology at UCL Louvain-la-Neuve, Belgium (2000) and omics at ENS Paris, France (2004). She earned an HDR in Omics from the University of Lille, France (2014). Her educational journey laid a strong foundation for her research in genomics, plant biology, and microbial ecosystems. 🎓🔬🌱

Experience

Dr. Lucau-Danila has held various esteemed academic positions since 2004, including Assistant Professor at the University of Lille. She directs the SOPHYA International Associated Laboratory and leads the Chicory for One Health team. As Head of the Transcriptomic Platform of UMRtBioEcoAgro, she has supervised 12 PhD students and several postdocs. Additionally, she serves on scientific committees and has been an expert evaluator for ANSES projects. Her leadership and collaborative research efforts have contributed to advancing scientific knowledge in her field. 👩‍🏫💼📚

Awards and Honors

Dr. Lucau-Danila has received numerous recognitions for her scientific contributions. She is a member of the Conseil Scientifique de l’Environnement du Nord Pas de Calais and the Société Botanique du Nord de la France. Her research has garnered international acclaim, reflected in her 37 peer-reviewed publications and 7,467 citations. She has been a dedicated expert evaluator for ANSES and is an associated editor for the Annals of Forest Research. 🏆🌍🎖️

Research Focus

Dr. Lucau-Danila’s research spans three primary areas: 1) transcriptomic responses of plants to environmental stresses, 2) nutrigenomics through DNA microarrays and RNA-seq, and 3) microbial ecosystems within the One Health approach using metagenomic analyses. Her work bridges plant biology and microbiology, aiming to understand stress responses and ecosystem health for sustainable agriculture and environmental protection. 🌱🧬🌿

Publication Top Notes

  • Genomic Analyses of Weissella cibaria W25, a Potential Bacteriocin-Producing Strain – Microorganisms (2022) 🌍🔬

  • Chicory: Understanding the Effects and Effectors of This Functional Food – Nutrients (2022) 🥬💪

  • Vaginal Microbiota: Age Dynamic and Ethnic Particularities of Algerian Women – Microbial Ecology (2021) 🌱🧬

  • A Leaderless Two-Peptide Bacteriocin, Enterocin DD14, Is Involved in Its Own Self-Immunity – Frontiers in Bioengineering and Biotechnology (2020) 🧫🛡️

  • Chicory Root Flour – A Functional Food with Potential Multiple Health Benefits Evaluated in a Mice Model – Journal of Functional Foods (2020) 🐭🥗

  • High-Dose Dietary Supplementation with Zinc Prevents Gut Inflammation – FASEB Journal (2020) 🧬🛡️

  • Metabolic Shift of an Isogenic Strain of Enterococcus faecalis 14, Deficient in Its Own Bacteriocin Synthesis – International Journal of Molecular Sciences (2020) 🦠🔍

  • Chicory Roots for Prebiotics and Appetite Regulation: A Pilot Study in Mice – Journal of Agricultural and Food Chemistry (2018) 🌱🍽️

  • Intra-Platform Comparison of 25-mer and 60-mer Oligonucleotide Nimblegen DNA Microarrays – BMC Research Notes (2013) 🧬💡

  • Exploring Chloroplastic Changes Related to Chilling and Freezing Tolerance During Cold Acclimation of Pea – Journal of Proteomics (2013) 🌿❄️

Julio César Fernández Travieso | Clinical Pharmacology | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Julio César Fernández Travieso | Clinical Pharmacology | Best Researcher Award

Prof. Dr. Julio César Fernández Travieso, National Centre for Scientific Research, Cuba

Prof. Dr. Julio César Fernández Travieso is a distinguished Cuban pharmaceutical scientist and Head of the Clinical Trials Unit at the National Centre for Scientific Research in Havana. He earned his BSc in Pharmaceutical Sciences in 1996 and completed his PhD in 2003. As a Senior Researcher and Full Academician of the Cuban Academy of Sciences, he has made significant contributions to the clinical development of natural-origin pharmaceuticals. With over 150 scientific publications and more than 120 conference presentations, his work has had a wide-reaching impact on experimental pharmacology and clinical research in Cuba.

Publication Profile

Scopus

Orcid

🎓 Education

Prof. Dr. Fernández Travieso completed his Bachelor of Science in Pharmaceutical Sciences from Havana University in 1996. He pursued advanced academic training and was awarded a PhD in Pharmaceutical Sciences in 2003. His education provided a comprehensive foundation in experimental pharmacology, pharmaceutical formulation, and clinical research methodologies. These qualifications enabled him to lead major clinical studies and serve in senior research roles. His academic background is firmly rooted in the development of therapeutics derived from natural sources, particularly those innovated in Cuba.

💼 Experience

Dr. Julio César Fernández Travieso currently serves as the Head of the Clinical Trials Unit at the National Centre for Scientific Research, Havana. With a career spanning over two decades, he has led multiple Phase I–IV clinical trials for novel therapeutics developed in Cuba. He is a Senior Investigator specializing in Clinical Pharmacology and has contributed to drug development, safety monitoring, and pharmacodynamic studies. His leadership has enabled the translation of research into approved therapeutic products. He also holds the title of Full Academician of the Cuban Academy of Sciences.

🏅 Awards and Honors

Prof. Dr. Fernández Travieso has received numerous national and international recognitions for his work in pharmaceutical sciences and clinical research. Several of his more than 120 scientific presentations have earned awards at global conferences. His appointment as a Full Academician of the Cuban Academy of Sciences highlights his standing in the scientific community. These honors reflect his role in advancing Cuba’s pharmaceutical innovation, particularly in clinical evaluation and development of natural products. His contributions have positioned him as a scientific leader in Latin America’s biomedical research landscape.

🔍 Research Focus

Dr. Fernández Travieso’s primary research interest lies in experimental pharmacology and conducting Phase I–IV clinical trials of natural-origin pharmaceuticals. He has played a pivotal role in evaluating and validating Cuban-developed products such as Policosanol, Abexol, Prevenox, Vasoactol, and Palmex. His work bridges laboratory pharmacology and clinical application, ensuring rigorous scientific evidence supports therapeutic claims. His research addresses chronic conditions like cardiovascular and metabolic disorders using innovative natural compounds. He also explores drug safety, efficacy, and pharmacokinetics in human populations.

Publication Top Notes

  • Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double-Blind, Multicentre Study 🧑‍⚕️, 2025

  • Comparative Study of the Efficacy and Safety of the Ozonated Sunflower Oil, Ketoconazole and Terbinafine in Patients with Dermatophytosis 💊, 2024

  • Beeswax Alcohol Prevents Low-Density Lipoprotein Oxidation and Demonstrates Antioxidant Activities in Zebrafish Embryos and Human Subjects: A Clinical Study 🧬, Cited by: 6, 2024

  • Effects of Policosanol in Patients with Metabolic Syndrome: A Six-Month Study 💉, Cited by: 6, 2020

  • Efficacy and Tolerability of Roystonea Regia Lipid Extract (D-004) and Terazosin in Men with Symptomatic Benign Prostatic Hyperplasia: A 6-Month Study 🔬, Cited by: 7, 2019

  • Concomitant Use of Policosanol and Antiplatelet Drugs in Older Patients 💊, 2019

  • Non-Cardioembolic Ischemic Stroke Hypertensive Patients, A Therapeutic Hope. Reply 🧠, 2019

 

Yanlian Chen | Senescence | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Yanlian Chen | Senescence | Best Researcher Award

Assoc. Prof. Dr. Yanlian Chen, Sun Yat-sen University, China

Dr. Yanlian Chen is an Associate Professor at The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China. She earned her Ph.D. in Cell Biology and B.Sc. in Biotechnology from Sun Yat-sen University. Dr. Chen’s research advances understanding of vascular calcification, cancer immunotherapy, telomere biology, and viral infection control. She has led multiple national and provincial research projects and holds several patents. Her work is widely published in prestigious journals like Cancer Immunology Research and Signal Transduction and Targeted Therapy. She is an active member of leading medical associations, contributing significantly to vascular and hypertension research. 🌟

Publication Profile

Scopus

Education 📚

Yanlian Chen completed her Bachelor of Science in Biotechnology (2009-2013) and Ph.D. in Cell Biology (2013-2018) at the School of Life Sciences, Sun Yat-sen University, China. During her academic training, she gained extensive expertise in molecular biology, cellular signaling pathways, and translational medicine. Her doctoral research provided deep insights into telomere maintenance and RNA-binding proteins, laying a strong foundation for her future work on vascular calcification and immune modulation. Her comprehensive education enabled her to develop a multidisciplinary approach, bridging molecular mechanisms with clinical applications in vascular disease and cancer biology. 🎓

Experience 🧪

Dr. Chen began her academic career as a Postdoctoral Fellow at Sun Yat-sen University (2018-2021), where she studied tumor DNA damage tolerance. She then progressed to Assistant Researcher (2021-2024) and now serves as Associate Researcher (2024–present) at The Eighth Affiliated Hospital of Sun Yat-sen University. Throughout her career, she has spearheaded numerous high-impact research projects, managed interdisciplinary collaborations, and contributed to innovations in vascular health and cancer immunotherapy. Her clinical translational focus blends fundamental cell biology with therapeutic intervention strategies, leading to both significant publications and multiple patents. 🔬

Awards and Honors 🏆

Dr. Chen has been recognized for her excellence in research with prestigious awards, including the Third Prize of the Chinese Medical Science and Technology Award by the Chinese Medical Association in 2023 and the First Prize from the Guangdong Medical Association the same year. These honors reflect her pioneering work in understanding and intervening in hypertension-induced vascular injury. Additionally, she holds important professional roles, such as Standing Committee Member positions in the Pan-Vascular Disease Professional Committee and the Hypertension Branch of Guangdong Precision Medicine Application Society. Her accolades highlight her leadership and innovation in biomedical research. 🥇

Research Focus 🔬

Dr. Chen’s research focuses on the molecular mechanisms regulating vascular calcification, cancer immunotherapy targeting PD-L1 pathways, telomere stability, and anti-viral strategies against SARS-CoV-2. Her work integrates cellular biology with translational medicine, particularly investigating the roles of SIRT1 ubiquitination, MOV10/TERRA axis, and Let-7 microRNA pathways. She also explores therapeutic interventions for vascular aging and damage through metabolic modulation and immune checkpoint inhibitors. Her studies are aimed at developing novel clinical treatments for cardiovascular diseases and cancer, bridging laboratory discoveries with real-world health applications. Her research is cutting-edge and highly impactful. ⚡

Publication Top Notes

The transcription factor GATA6 accelerates vascular smooth muscle cell senescence-related arterial calcification by counteracting the role of anti-aging factor SIRT6 and impeding DNA damage repair